India  

"China S Sinopharm"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 

WHO approves China's Sinopharm vaccine for emergency use [Video]

WHO approves China's Sinopharm vaccine for emergency use

Sinopharm can now be used and distributed as part of the COVAX mechanism.

Credit: Euronews English     Duration: 01:40Published
200,000 Russian Sputnik V vaccines arrive in Bolivia [Video]

200,000 Russian Sputnik V vaccines arrive in Bolivia

The second batch of the Russian Sputnik V coronavirus vaccine has arrived in Bolivia. According to the ministry, as many as 333,137 people have been vaccinated against Covid-19.

Credit: Newsflare STUDIO     Duration: 03:25Published

You Might Like


Covid-19: Frequently asked questions about China's Sinopharm vaccine


IndiaTimes - Published

Vaccination centres at Pakistan's Rawalpindi report shortage of China's Sinopharm Covid-19 vaccine


newKerala.com - Published

WHO approves China's second COVID-19 vaccine 'Sinovac' for emergency use

On May 7, WHO granted conditional approval to China's Sinopharm COVID-19 vaccine for emergency use, which helped Beijing to step up its vaccine diplomacy amid the virus surge.
Zee News - Published Also reported by •newKerala.com

Sri Lanka furious over China for selling COVID-19 vaccine at higher prices

Disclosure of procurement price of China`s Sinopharm vaccine in Sri Lanka has sparked a row after reports emerged that Colombo had to shell out a higher per-dose price than its fellow South Asian..
Zee News - Published

China's Sinopharm publishes awaited COVID vaccine trial data; fails to cover vulnerable groups


newKerala.com - Published

COVID-19: WHO approves emergency use of China's Sinopharm COVID-19 vaccine


newKerala.com - Published Also reported by •DNAIndian ExpressIndiaTimes

China approves new COVID-19 vaccine for clinical trials

A new COVID-19 vaccine developed by China`s Sinopharm has recently been approved for clinical trials.
Zee News - Published

Sri Lanka receives 600,000 doses of China's Sinopharm vaccine: Official

The Chinese Sinopharm vaccine will be used on the Chinese workers currently in Sri Lanka.
Hindu - Published

New UAE plant to make Covid-19 vaccine from China's Sinopharm


IndiaTimes - Published

Maldives approves China's Sinopharm vaccine for emergency use


newKerala.com - Published

Nepal to buy 2 million doses of Covid vaccine from India

Nepal approved on Thursday the emergency use of a Covid-19 vaccine developed by an affiliate of China’s Sinopharm, a government official said, the second vaccine cleared after Oxford-AstraZeneca's..
IndiaTimes - Published

'China's Sinopharm vaccine not effective for those over 60 yrs'

Pakistan on Thursday said that China's Sinopharm vaccine is not effective for people over 60 years of age, a day after it began its countrywide coronavirus vaccination programme with the Chinese jabs...
IndiaTimes - Published

Pakistan begins COVID-19 vaccination programme

It is using China’s Sinopharm vaccine
Hindu - Published

Pak authorises emergency use of Russia's Sputnik V vaccine

Pakistan's Drug Regulatory Authority has approved the emergency use of the Russian-made vaccine against the coronavirus disease, Gam-COVID-Vac, commonly known as Sputnik V. The regulatory authority..
IndiaTimes - Published

Pak to purchase 1.2 mn vaccine doses from China

Pakistan will purchase 1.2 million Covid-19 vaccine doses from China's Sinopharm, a minister said on Thursday, the first official confirmation of a vaccine purchase by the South Asian country as it..
IndiaTimes - Published

China's Sinopharm says vaccine '79% effective'

Phase 3 trials of a Sinopharm coronavirus vaccine in China have been found to be 79 percent effective, the Chinese pharma giant said Wednesday. It is however lower than rival jabs developed by..
IndiaTimes - Published

Britain tells people with serious allergy to not take Pfizer vaccine

Regulators warned on Wednesday that people who have a history of serious allergic reactions shouldn't receive the new Pfizer-BioNTech vaccine as they investigate two adverse reactions that occurred on..
Mid-Day - Published